7-Amino-3-(sulfonic acid and sulfamoyl substituted
tetrazolythiomethyl)cephalosporin intermediates
    141.
    发明授权
    7-Amino-3-(sulfonic acid and sulfamoyl substituted tetrazolythiomethyl)cephalosporin intermediates 失效
    7-氨基-3-(磺酸和氨磺酰基取代的四唑硫代甲基)头孢菌素中间体

    公开(公告)号:US4139701A

    公开(公告)日:1979-02-13

    申请号:US795585

    申请日:1977-05-10

    申请人: David A. Berges

    发明人: David A. Berges

    摘要: The compounds of this invention are cephalosporins having various acyl substituents at the 7-position and a sulfonic acid or sulfamoyl substituted tetrazolyl thiomethyl group at the 3-position of the cephem nucleus and intermediates for the preparation thereof. The 7-acylated compounds have antibacterial activity.

    摘要翻译: 本发明的化合物是在7-位上具有各种酰基取代基的头孢菌素和头孢烯核的3位上的磺酸或氨磺酰取代的四唑基硫代甲基以及制备它们的中间体。 7-酰化化合物具有抗菌活性。

    7-Acylamino-3-[1-(2-sulfamidoethyl)tetrazol-5-ylthiomethyl]-3-
cephem-4-carboxylic acids
    142.
    发明授权
    7-Acylamino-3-[1-(2-sulfamidoethyl)tetrazol-5-ylthiomethyl]-3- cephem-4-carboxylic acids 失效
    7-乙酰氨基-3-(1-(2-磺酰基乙基)四唑-5-基]乙酰基)-3-羧基-4-羧酸

    公开(公告)号:US4117123A

    公开(公告)日:1978-09-26

    申请号:US805197

    申请日:1977-06-09

    申请人: David Alan Berges

    发明人: David Alan Berges

    CPC分类号: C07D257/04 C07D501/36

    摘要: Novel cephalosporins having various acyl substituents at the 7- position and a sulfamidoethyl substituted tetrazolylthiomethyl group at the 3- position of the cephem nucleus are prepared. These compounds have antibacterial activity.

    摘要翻译: 7-酰基-3-头孢烯-4-羧酸,其制备方法和含有它们的组合物。 具有下式的头孢菌素:其中R表示已知可用作头孢菌素中7-氨基或青霉素6-氨基上的取代基的药学上可接受的酰基具有抗菌活性。 通过将适当取代的头孢菌素或7-氨基头孢菌素的3-乙酰氧基甲基与1-(2-氨基磺酰氨基乙基)1,4-二氢-5H-四唑-5-硫酮置换乙酰基来制备化合物,如果 需要引入所需的7-酰基。

    Cephalosporin-type antibiotics and process for producing the same
    143.
    发明授权
    Cephalosporin-type antibiotics and process for producing the same 失效
    CEPHALOSPORIN型抗生素及其生产方法

    公开(公告)号:US4113944A

    公开(公告)日:1978-09-12

    申请号:US588555

    申请日:1975-06-19

    CPC分类号: C07D501/36

    摘要: A cephalosporin compound represented by the formula (I) or (I') ##STR1## wherein R.sup.1 represents a phenyl group, a 2-thienyl group or a phenoxy group; R.sup.2 represents a hydrogen atom, an alkyl group having 1 to 4 carbon atoms which may be substituted with a phenyl group, an alkoxy group having 1 to 4 carbon atoms or a halogen atom, or a phenyl group which may be substituted with one or two groups selected from the group consisting of a halogen atom, a nitro group, an alkyl group having 1 to 4 carbon atoms and an alkoxy group having 1 to 4 carbon atoms; R.sup.3 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms which may be substituted with a monoalkylamino group having 1 to 4 carbon atoms in the alkyl moiety thereof, a dialkylamino group having 1 to 4 carbon atoms in each alkyl moiety thereof, a halogen atom or a phenyl group which may be substituted with one to three groups selected from the group consisting of a halogen atom, a nitro group, an alkyl group having 1 to 4 carbon atoms and an alkoxy group having 1 to 4 carbon atoms; R.sup.4 represents an alkyl group having 1 to 4 carbon atoms; A has up to 15 carbon atoms and represents a straight or branched chain alkylene group, a straight or branched chain alkenylene group, a straight or branched chain alkadienylene group or a phenylene group, and n is 0 or 1; or the salt thereof; and a process for preparing the same.

    Carbamoylalkylureido cephalosporins
    146.
    发明授权
    Carbamoylalkylureido cephalosporins 失效
    氨基甲酰基烷基脲基头孢菌素

    公开(公告)号:US4086422A

    公开(公告)日:1978-04-25

    申请号:US714420

    申请日:1976-08-16

    CPC分类号: C07D501/36 C07D501/20

    摘要: Carbamoyalkylureido cephalosporins of the formula ##STR1## wherein R is hydrogen, lower alkyl, phenyl-lower alkyl, diphenyl-lower alkyl, tri(lower alkyl)silyl, trihaloethyl, a salt forming ion, or the group ##STR2## R.sub.1 is hydrogen or methoxy; A is straight or branched chain alkylene of 1 to 6 carbons; R.sub.2 and R.sub.3 are independently selected from hydrogen and straight chain alkyl of 1 to 4 carbons, or R.sub.2 is hydrogen and R.sub.3 is branched chain alkyl of 3 or 4 carbons, phenyl, benzyl or phenethyl, or R.sub.2 and R.sub.3 taken together with N atom to which they are attached form ##STR3## R.sub.4 is hydrogen or lower alkyl; R.sub.5 is hydrogen, lower alkyl, cycloalkyl, cycloalkenyl, cycloalkadienyl, phenyl, phenyl-lower alkyl, substituted phenyl, substituted phenyl-lower alkyl, or certain heterocyclic groups; R.sub.6 is hydrogen or lower alkyl; R.sub.7 is lower alkyl; and X is hydrogen, lower alkanoyloxy, ##STR4## or certain heterothio groups; are disclosed. These compounds are useful as antibacterial agents.

    摘要翻译: 其中R为氢,低级烷基,苯基 - 低级烷基,二苯基 - 低级烷基,三(低级烷基)甲硅烷基,三卤代乙基,成盐离子或基团R1为氢或碳原子数为1的碳原子数1〜8的烷硫基烷基脲基头孢菌素 甲氧基 A是1至6个碳的直链或支链亚烷基; R2和R3独立地选自氢和1至4个碳的直链烷基,或者R2是氢,R3是3或4个碳的支链烷基,苯基,苄基或苯乙基,或R2和R3与N原子一起 它们是连接的,其中R 4是氢或低级烷基; R5是氢,低级烷基,环烷基,环烯基,环链二烯基,苯基,苯基 - 低级烷基,取代的苯基,取代的苯基 - 低级烷基或某些杂环基; R6是氢或低级烷基; R7是低级烷基; X是氢,低级烷酰氧基,或者某些杂硫基; 被披露。 这些化合物可用作抗菌剂。

    7-[.alpha.-(GUANYL-1-UREIDO)PHENYLACETAMIDO]-3-SUBSTITUTED CEPHALOSPORIN
ANTIBIOTICS
    147.
    发明授权
    7-[.alpha.-(GUANYL-1-UREIDO)PHENYLACETAMIDO]-3-SUBSTITUTED CEPHALOSPORIN ANTIBIOTICS 失效
    7- {8- {6-(GUANYL-1-UREIDO)苯基乙酰胺(9 - 3-取代的CEPHOROSPORIN抗生素)

    公开(公告)号:US4039535A

    公开(公告)日:1977-08-02

    申请号:US663885

    申请日:1976-03-04

    IPC分类号: C07D501/36

    CPC分类号: C07D501/36

    摘要: 7-[.alpha.-(guanyl-1-ureido)phenylacetamido]-3-(1-methyl-1H-tetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid, 7-[.alpha.-(3-guanyl-1-ureido)phenylacetamido]-3-(5-methyl-1,3,4-thiadiazol-2-ylthiomethyl)-3-cephem-4-carboxylic acid and related compounds, the pharmaceutically acceptable non-toxic salts and certain esters thereof are valuable broad spectrum antibiotics demonstrating high levels of activity against Pseudomonas species.

    摘要翻译: 7- [α-(脒基-1-脲基)苯基乙酰氨基] -3-(1-甲基-1H-四唑-5-基噻吩基)-3-头孢烯-4-羧酸,7- [3- -1-脲基)苯基乙酰氨基] -3-(5-甲基-1,3,4-噻二唑-2-基硫代甲基)-3-头孢烯-4-羧酸及其相关化合物,药学上可接受的无毒盐和某些 其酯是有价值的广谱抗生素,表现出对假单胞菌属物种的高水平活性。

    Aqueous suspensions of
7-[D-.alpha.-amino-.alpha.-(p-hydroxyphenyl)-acetamido]-3-(1,2,3-triazol
-5-ylthiomethyl)-3-cephem-4-carboxylic acid 1,2-propylene glycolate
    149.
    发明授权
    Aqueous suspensions of 7-[D-.alpha.-amino-.alpha.-(p-hydroxyphenyl)-acetamido]-3-(1,2,3-triazol -5-ylthiomethyl)-3-cephem-4-carboxylic acid 1,2-propylene glycolate 失效
    7- {8 D- {60-氨基 - {60-(对羟基苯基) - 乙酰氨基{9-3(1,2,3-三唑-5-基硫甲基)-3-头孢烯-4-羧酸 酸1,2-丙二醇酯

    公开(公告)号:US4034089A

    公开(公告)日:1977-07-05

    申请号:US664218

    申请日:1976-03-05

    IPC分类号: A61K31/545

    CPC分类号: C07D501/36 A61K31/545

    摘要: The antibacterial agent 7-[D-.alpha.-amino-.alpha.-(p-hydroxyphenyl)acetamido]-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid, which is a zwitterion, is both purified and converted to a form highly suitable for use in aqueous suspensions by converting it to the crystalline 7-[D-.alpha.-amino-.alpha.-(p-hydroxyphenyl)acetamido]-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid 1,2-propylene glycolate, said propylene glycolate containing 1.0 - 1.6 moles of 1,2-propylene glycol per mole of cephalosporin zwitterion.

    摘要翻译: 抗菌剂7- [D-α-氨基-α-(对羟基苯基)乙酰氨基] -3-(1,2,3-三唑-5-基硫甲基)-3-头孢烯-4-羧酸,其为 将两性离子两者纯化并转化成高度适用于水性悬浮液的形式,将其转变为结晶7- [D-α-氨基-α-(对羟基苯基)乙酰氨基] -3-(1,2,3 - 三唑-5-基硫甲基)-3-头孢烯-4-羧酸1,2-丙二醇乙酸酯,所述丙二醇酸酯每摩尔头孢菌素两性离子含有1.0-1.6摩尔1,2-丙二醇。

    7-(.alpha.-SULFOACYLAMIDO) CEPHALOSPORANIC ACIDS
    150.
    发明授权
    7-(.alpha.-SULFOACYLAMIDO) CEPHALOSPORANIC ACIDS 失效
    7 - ({60 -SULFOACYLAMIDO)CEPHALOSPORANIC酸

    公开(公告)号:US4029656A

    公开(公告)日:1977-06-14

    申请号:US711565

    申请日:1976-08-04

    摘要: Novel cephalosporanic acid derivatives which are active against both Gram positive and Gram negative pathogenic bacteria, particularly Pseudomonas, and which have .alpha.-sulfoacylamino group at 7-position. A few examples of the compounds are 7-(.alpha.-sulfophenylacetamido)-cephalosporanic acid, 7-(.alpha.-sulfopropionamido)-cephalosporanic acid, 7-(.alpha.-sulfocapronamido)-cephalosporanic acid. They are prepared by condensing 7-aminocephalosporanic acid or salts thereof with .alpha.-sulfocarboxylic acid or functional derivatives thereof in the presence of a solvent at -2.degree. - 10.degree. C.

    摘要翻译: 新型头孢菌素酸衍生物,其对革兰氏阳性和革兰氏阴性致病菌特别是假单胞菌具有活性,并且在7-位具有α-磺酰氨基。 化合物的一些实例是7-(α-磺基苯基乙酰胺基) - 头孢烷酸,7-(α-亚磺基丙酰氨基) - 头孢烷酸,7-(α-磺基己内酰胺基) - 头孢烷酸。 它们通过将7-氨基头孢烷酸或其盐与α-磺基羧酸或其官能衍生物在溶剂存在下在-2°-10℃下进行缩合来制备。